Sex, drugs and sports: Prostaglandins, epitestosterone and sexual development

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 829-835

  Sanders, Bryan K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ACETYLSALICYLIC ACID; ALLYLAMINE; ANDROSTERONE; ANTIFUNGAL AGENT; CHORIONIC GONADOTROPIN; CYCLOOXYGENASE 2 INHIBITOR; ENZYME; EPITESTOSTERONE; FLUTAMIDE; GONADORELIN; IMIDAZOLE; INDOMETACIN; KETOCONAZOLE; LUTEINIZING HORMONE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; PROSTAGLANDIN E2; TERBINAFINE; TESTOSTERONE; TRAMADOL; UNCLASSIFIED DRUG;

ARTICLE; DOPING; ENZYME ACTIVITY; FEMUR; GONADORELIN RELEASE; HUMAN; HYPOTHALAMUS; KIDNEY; LUTEINIZING HORMONE RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; SEMINAL VESICLE; SEXUAL DEVELOPMENT; SPORT; STEROIDOGENESIS; VIRILIZATION;

ANIMALS; DOPING IN SPORTS; EPITESTOSTERONE; FEMALE; HUMANS; MALE; MODELS, ANIMAL; MODELS, PSYCHOLOGICAL; SEXUAL BEHAVIOR; SEXUAL DEVELOPMENT; SPORTS;

RATTUS;

EID: 34547840268     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.12.058     Document Type: Article

References (45)

1. Lapčík O., Hampl R., Hill M., and Stárka L. Plasma levels of epitestosterone from prepuberty to adult life. J Steroid Biochem Mol Biol 55 (1995) 405-408
2. Havlíková H., Hill M., Hampl R., and Stárka L. Sex- and age-related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J Clin Endocrinol Metab 87 (2002) 2225-2231
3. WADA Standards and Harmonization/Science and Research, Guideline Reporting & Management of Elevated T/E Ratios (Version 1, March 2006).
4. Carlström K., Palonek E., Garle M., Stanghelle J., and Björkhem I. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 α-hydroxyprogesterone. Clin Chem 38 (1992) 1779-1784
5. Bičíková M., Hampl R., and Stárka L. Does epitestosterone function as an endogenous antiandrogen?. Cas Lek Cesk 128 (1989) 754-755
6. Stárka L., and Broulik P.D. Antiandrogenic activity of epitestosterone in male mice in vivo. Sb Lek 102 (2001) 7-11
7. Bellemare V., Faucher F., Breton R., and Luu-The V. Characterization of 17 α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone. BMC Biochemistry 6 (2005) 12
8. Stárka L., Hampl R., Hill M., Lapcik O., Bilek R., and Petrik R. Epitestosterone in human blood and prostatic tissue. Eur J Clin Chem Clin Biochem 35 (1997) 469-473
9. Kanda N., and Watanabe S. Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2 and CCL5 production in human keratinocytes. Biochem Pharmacol 72 (2006) 463-473
10. Conte D., Romanelli F., Fillo S., et al. Aspirin inhibits androgen response to chorionic gonadotropin in humans. Am J Physiol Endocrinol Metab 277 (1999) 1032-1037
11. Buccellati C., Sala A., Ballerio R., and Bianchib M. Tramadol anti-inflammatory activity is not related to direct inhibitory action on prostaglandin endoperioxide synthase. Eur J Pain 4 (2000) 413-415
12. Conte D., Nordio M., Fillo S., De Giorgio G., Isidori A., and Romanelli F. Aspirin inhibition of naloxone-induced luteinizing hormone secretion in man. J Clin Endocrinol Metab 81 (1996) 1772-1775
13. Ayub M., and Levell M.J. Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs. J Steroid Biochem 28 (1987) 521-531
14. 5 steroidogenic pathway. J Clin Endocrinol Metab 88 (2003) 3762-3766
15. 2 by estradiol mediates developmental masculinization of sex behavior. Nat Neurosci 7 (2004) 643-650
16. Penning T.M., Sharp R.B., and Krieger N.R. Purification and properties of 3α-hydroxysteroid dehydrogenase from brain cytosol. Inhibition by nonsteroidal anti-inflammatory drugs and progestins. J Biol Chem 260 (1985) 15266-15272
17. Penning T.M., Mukharji I., Barrows S., and Talalay P. Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem J 222 (1984) 601-611
18. +-dependent 3 alpha-hydroxysteroid dehydrogenase from mouse liver cytosol. Biochem J (Tokyo) 103 (1988) 1027-1034
19. Beyer C., Gonzalez-Flores O., Ramirez-Orduna J.M., and Gonzalez-Marisca G. Indomethacin inhibits lordosis induced by ring A-reduced progestins: possible role of 3 alpha-oxidoreduction in progestin-facilitated lordosis. Horm Behav 35 (1999) 1-8
20. Penning T.M., Jin Y., Heredia V.V., and Lewis M. Structure-function relationships in 3α-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms. J Steroid Biochem Mol Biol 85 (1987) 247-255
21. Bellemare V., Labrie F., and Luu-The V. Isolation and characterization of a cDNA encoding mouse 3 alpha-hydroxysteroid dehydrogenase: an androgen-inactivating enzyme selectively expressed in female tissues. J Steroid Biochem Mol Biol 98 (2006) 18-24
22. Hardy D.O., Ren-Shan G.E., Catterall J.F., Hou Y.T., Penning T.M., and Hardy M.P. Indentification of the oxidative 3α-hydroxysteroid dehydrogenase activity of rat leydig cells as type II retinol dehydrogenase. Endocrinology 141 (2000) 1608-1617
23. Penning T.M., and Talalay P. Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. Proc Natl Acad Sci 80 (1983) 4504-4508
24. Lau P.C., Layne D.S., and Williamson D.G. Comparison of the multiple forms of the soluble 3(17) alpha-hydroxysteroid dehydrogenase of female rabbit kidney and liver. J Biol Chem 257 (1982) 9450-9456
25. Didolkar A.K., Gurjar A., Joshi U.M., Sheth A.R., and Roychowdhury D. Effect of aspirin on blood plasma levels of testosterone, LH and FSH in maturing male rats. Int J Androl 3 (1980) 312-318
26. Wang X., Dyson M.T., Jo Y., and Stocco D.M. Inhibition of cyclooxgenase-2 activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells. Endocrinology 144 (2003) 3368-3375
27. Carmichael R., Belanger A., Cusan L., Seguin C., Caron S., and Labrie F. Increased testicular 5 alpha-androstane-3 alpha, 17 beta-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat. Steroids 36 (1980) 383-391
28. Wisner Jr. J.R., and Stalvey J.R. Alteration in the normal pattern of serum testosterone and 5 alpha-androstane-3 alpha, 17 beta-diol in the immature male rat following chronic treatment with luteinizing hormone releasing hormone or luteinizing hormone. Steroids 36 (1980) 337-348
29. Smithgall T.E., and Penning T.M. Sex differences in Indomethacin-sensitive 3α-hydroxysteroid dehydrogenase of rat liver cytosol. Cancer Res 45 (1985) 4946-4949
30. Ge R.S., Hardy O.D., Catterall J.F., and Hardy M.P. Opposing changes in 3 alpha-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells during pubertal development. Biol Reprod 60 (1999) 855-860
31. Munalulu B.M., Hillier K., and Peddie M.J. Effect of human chorionic gonadotrophin and Indomethacin on ovulation, steroidogenesis and prostaglandin synthesis in preovulatory follicles of PMSG-primed immature rats. J Reprod Fertil 80 (1987) 229-234
32. Frye C.A., and Vongher J.M. Ventral tegmental area infusions of inhibitors of the biosynthesis and metabolism of 3 alpha,5alpha-THP attenuate lordosis of hormone-primed and behavioural oestrous rats and hamsters. J Neuroendocrinol 13 (2001) 1076-1086
33. Ward I.L., Ward O.B., Affuso J.D., Long III W.D., French J.A., and Hendricks S.E. Fetal testosterone surge: specific modulations induced in male rats by maternal stress and/or alcohol consumption. Horm Behav 43 (2003) 531-539
34. Falk O., Palonek E., and Björkhem I. Effect of ethanol on the ratio between testosterone and epitestosterone in urine. Clin Chem 34 (1988) 1462-1464
35. Johnson D.C., Tsai-Morris C.H., and Hoversland R.C. Steroid 17 alpha-hydroxylase activity of ovarian granulosa cells from hypophysectomized immature rats treated with pregnant mare's serum gonadotropin (PMS). Steroids 38 (1981) 581-592
36. Erskine M.S. Effect of 5 alpha-dihydrotestosterone and flutamide on the facilitation of lordosis by LHRH and naloxone in estrogen-primed female rats. Physiol Behav 45 (1989) 753-759
37. Gladue B.A. Dihydrotestosterone stimulates mounting behavior but not lordosis in female rats. Physiol Behav 33 (1984) 49-53
38. Dohanich G.P., and Clemens L.G. Inhibition of estrogen-activated sexual behavior by androgens. Horm Behav 17 (1983) 366-673
39. Erskine M.S. Effects of an anti-androgen and 5 alpha-reductase inhibitors on estrus duration in the cycling female rat. Physiol Behav 30 (1983) 519-524
40. Skinner D.C., Evans N.P., Delaleu B., Goodman R.L., Bouchard P., and Caraty A. The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc Natl Acad Sci USA 95 (1998) 10978-10983
41. Frye C.A., and Rhodes M.E. Progesterone's 5 alpha-reduced metabolite, 3 alpha,5alpha THP, mediates lateral displacement of hamsters. Brain Res 1038 (2005) 59-68
42. Wilson J., and Wilson H. Reproductive capacity in adult male rats treated prepubertally with androgenic hormone. Endocrinology 33 (1943) 353-360
43. Margolese S., and Janiger O. Androsterone/etiocholanolone ratios in male homosexuals. Brit J Med 3 (1973) 207-210
44. 19 Steroids by rat liver homogenates. J Biol Chem 227 (1957) 917-928
45. Kaminski R.M., Marini H., Kim W.-J., and Rogawski M.A. Anticonvulsant Activity of Androsterone and Etiocholanolone. Epilepsia 46 (2005) 819-827